Tracked deals
10
10 tracked deals across 2019-2022.
Operating Company
Healthcare
ProPharma
Raleigh, North Carolina, United States
ProPharma provides regulatory sciences, clinical research, quality and compliance, pharmacovigilance, medical information, and R&D technology services to pharmaceutical, biotechnology, and medical device companies. Its end-to-end solutions support products from early development through clinical research, regulatory approval, and commercialization.
- Focus Areas
- Regulatory Affairs and Regulatory Sciences, Clinical Research Services, Quality and Compliance
- Website
- www.propharmagroup.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
9 addon · 1 buyout
ProPharma Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
September 1, 2022
- Buyer
- ProPharma Group, Odyssey Investment Partners
- Target
- Kateric
- Industry
- Healthcare Services
- Location
- Michigan, United States
- Type
- Addon
ProPharma Group, an Odyssey Investment Partners–backed provider of regulatory, clinical, and compliance services, has acquired Kateric, a medical writing firm founded in 2004. The deal expands ProPharma's medical writing capabilities and brings Kateric's leadership and global writing resources into ProPharma's portfolio.
-
- Buyer
- ProPharma Group
- Target
- OneSource Regulatory, OneSource Regulatory Technology
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Addon
ProPharma Group, a PE-backed provider of regulatory, clinical and compliance services, has acquired OneSource Regulatory and OneSource Regulatory Technology to expand its regulatory, medical and marketing operations services and technology capabilities. The deal brings OneSource’s regulatory consulting and promotional/labeling review expertise (headquartered in McKinney, Texas) into ProPharma’s global life sciences services platform; Edgemont Partners acted as exclusive financial advisor to OneSource.
-
March 16, 2022
- Buyer
- ProPharma Group, Odyssey Investment Partners
- Target
- M Squared Associates
- Industry
- Healthcare Services
- Location
- United States
- Type
- Addon
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired M Squared Associates, a clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry. The acquisition expands ProPharma's med‑tech capabilities across clinical affairs, regulatory strategy and quality systems, enabling broader end‑to‑end support for device, combination product and diagnostic clients globally.
-
October 6, 2021
- Buyer
- ProPharma Group, Odyssey Investment Partners
- Target
- Pharmica Consulting
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Type
- Addon
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
-
August 10, 2021
- Buyer
- ProPharma Group, Odyssey Investment Partners
- Target
- iSafety Systems
- Industry
- Healthcare Services
- Location
- Telangana, India
- Type
- Addon
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Hyderabad-based iSafety Systems, a provider of end-to-end pharmacovigilance and safety solutions. The add-on expands ProPharma’s global pharmacovigilance capacity and regulatory/compliance capabilities, strengthening service coverage across 130+ countries.
-
May 27, 2021
- Buyer
- ProPharma Group, Odyssey Investment Partners
- Target
- The Planet Group
- Seller
- MidOcean Partners
- Industry
- Staffing & HR
- Location
- Illinois, United States
- Type
- Addon
ProPharma Group, a portfolio company of Odyssey Investment Partners, has reached an agreement to merge with/acquire The Planet Group. MidOcean Partners sold its majority stake in The Planet Group as part of the transaction; the combined company will expand ProPharma's global footprint and human capital services, creating a business with over 1,900 colleagues worldwide.
-
March 2, 2021
- Buyer
- ProPharma Group, Odyssey Investment Partners
- Target
- Diamond Pharma Services
- Industry
- Healthcare Services
- Location
- Essex, United Kingdom
- Type
- Addon
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a UK-based regulatory affairs, pharmacovigilance, and compliance consultancy. The deal expands ProPharma's global regulatory and pharmacovigilance capabilities and adds Diamond's ~85+ experts and UK footprint to ProPharma's existing suite of services.
-
September 22, 2020
- Buyer
- Odyssey Investment Partners, ProPharma Group management team (including Dawn Sherman)
- Target
- ProPharma Group
- Seller
- Linden Capital Partners
- Industry
- Healthcare Services
- Location
- Kansas, United States
- Type
- Buyout
Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.
-
- Buyer
- ProPharma Group, Linden Capital Partners
- Target
- Southwood Research
- Industry
- Healthcare Services
- Location
- Buckinghamshire, United Kingdom
- Type
- Addon
ProPharma Group, a portfolio company of Linden Capital Partners, has acquired Southwood Research, a Buckinghamshire-based provider of pre-approval regulatory science services to the pharmaceutical and biotech industries. The add-on expands ProPharma's regulatory affairs capabilities across the EU and strengthens its end-to-end regulatory service offering.
-
January 28, 2019
- Buyer
- ProPharma Group, Linden Capital Partners
- Target
- The Weinberg Group Inc.
- Industry
- Healthcare Services
- Location
- District of Columbia, United States
- Type
- Addon
ProPharma Group, a portfolio company of Linden Capital Partners, has acquired The Weinberg Group, a Washington, D.C.-based regulatory and compliance consultancy serving the pharmaceutical, biotech, and medical device industries. The deal expands ProPharma's pre-approval and pre-clinical regulatory capabilities and further integrates Weinberg's FDA-focused regulatory expertise into ProPharma's global life sciences compliance platform.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
9 tracked deals by ProPharma.
Staffing & HR Buyers & Acquisitions
1 tracked deal by ProPharma.
Acquisitions in Illinois
1 tracked deal by ProPharma.
Acquisitions in Kansas
1 tracked deal by ProPharma.
Acquisitions in Michigan
1 tracked deal by ProPharma.
Acquisitions in Pennsylvania
1 tracked deal by ProPharma.
Selling a company? Get in front of buyers like ProPharma
Turn tracked acquisition activity into an outreach-ready buyer list.